2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one

2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one - Names and Identifiers

Name	1,2,3,4-Tetrahydronorharman-1-one
Synonyms	1,2,3,4-Tetrahydronorharman-1-one 3,4-Dihydro-β-carboline-1(2H)-one 1,2,3,4-Tetrahydro-β-carboline-1-one 2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-one 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-
CAS	17952-82-8
EINECS	241-878-7

2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one - Physico-chemical Properties

Molecular Formula	C11H10N2O
Molar Mass	186.21
Boling Point	529.2℃ at 760mmHg
Appearance	Cryst.
Storage Condition	2-8℃

2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one - Introduction

1,2, 3,4-tetrahydro dronorharman-1-one(1,2, 3,4-tetrahydro dronorharman-1-one) is an organic compound with the following properties:

1. Appearance: colorless crystalline solid.
2. Solubility: soluble in ethanol, ether and chloroform and other organic solvents, insoluble in water.
3. Smell: has a special smell.
4. Molecular formula: C11H11NO.
5. Molecular weight: 173.21g/mol.
6. Melting Point: About 75-77 ℃.

In Terms of Use, 1,2, 3,4-tetrahydro dronorharman-1-one is mainly used for chemical research and synthesis of organic compounds. It can be used as an intermediate for stimulants and reagents, and plays an important role in drug synthesis, plant extract research, and organic synthesis.

The preparation method of the compound generally adopts the method of chemical synthesis. It can be generated by the reaction of indole -3-acid methyl ester with cis-amino-1, 2,3, 4-tetrahydropyridin -4-one. Specific synthesis methods can refer to the relevant organic synthesis literature and research papers.

Regarding safety information, due to the lack of comprehensive toxicological data, the toxicity and safety of 1,2, 3,4-tetrahydrronorharman-1-one have not been fully evaluated. During use, it is necessary to follow general laboratory safety practices, including wearing appropriate personal protective equipment (such as gloves, goggles) and ensuring reasonable ventilation conditions. At the same time, it is necessary to avoid direct contact with the skin and eyes, and avoid inhaling its dust or gas. If any discomfort or abnormal reactions occur, discontinue use immediately and seek medical advice.

Last Update：2024-04-09 21:11:58